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Nonadherence in hemodialysis: Associations with mortality, Hemodialysis is a lifesaving but complex therapy. It
hospitalization, and practice patterns in the DOPPS. makes enormous demands on patients with end-stage
Background. Nonadherence among hemodialysis patients renal disease (ESRD), thereby affecting their quality ofcompromises dialysis delivery, which could influence patient
life [1]. Adherence to complicated treatment regimensmorbidity and mortality. The Dialysis Outcomes and Practice
associated with hemodialysis is vital. The definition ofPatterns Study (DOPPS) provides a unique opportunity to
review this problem and its determinants on a global level. nonadherence and its assessment have both proven con-
Methods. Nonadherence was studied using data from the troversial [2, 3]. However, by compromising the delivery
DOPPS, an international, observational, prospective hemo- of dialysis, nonadherence can affect both patient morbid-dialysis study. Patients were considered nonadherent if they
ity and mortality, a finding that is well recognized [4].skipped one or more sessions per month, shortened one or
It has been known for some time that survival ofmore sessions by more than 10 minutes per month, had a serum
potassium level of 6.0 mEq/L, a serum phosphate level of ESRD patients is better in Europe and Japan in compari-
7.5 mg/dL (2.4 mmol/L), or interdialytic weight gain (IDWG) son with the United States after adjustments for age,
5.7% of body weight. Predictors of nonadherence were iden-
gender, and diabetes mellitus [5]. Reasons for these dif-tified using logistic regression. Survival analysis used the Cox
ferences are unclear. Differences in practice patternsproportional hazards model adjusting for case-mix.
Results. Skipping treatment was associated with increased may provide one explanation. A detailed examination
mortality [relative risk (RR)  1.30, P  0.01], as were exces- of practice patterns has been undertaken in the Dialysis
sive IDWG (RR  1.12, P  0.047) and high phosphate levels Outcomes and Practice Patterns Study (DOPPS), an
(RR  1.17, P  0.001). Skipping also was associated with
international, observational, prospective hemodialysisincreased hospitalization (RR  1.13, P  0.04), as were high
study initiated between 1996 and 1999 [6]. In additionphosphate levels (RR  1.07, P  0.05). Larger facility size
(per 10 patients) was associated with higher odds ratios (OR) to practice patterns, patient behavior and adherence to
of skipping (OR  1.03, P  0.06), shortening (OR  1.03, prescribed treatment may be other determinants of out-
P  0.05), and IDWG (OR  1.02, P  0.07). An increased comes. A few studies have looked at the effect of nonad-percentage of highly trained staff hours was associated with
herence on outcomes, but these have been based mainlylower OR of skipping (OR 0.84 per 10%, P 0.02); presence
on patients from the United States, used a limited setof a dietitian was associated with lower OR of excessive IDWG
(OR  0.75, P  0.08). of variables, utilized relatively small sample sizes, and
Conclusion. Nonadherence was associated with increased have not always measured the long-term consequences
mortality risk (skipping treatment, excessive IDWG, and high
of nonadherence. Two studies have shown that nonad-phosphate) and with hospitalization risk (skipping, high phos-
herence to the hemodialysis regimen is associated withphate). Certain patient/facility characteristics also were associ-
ated with nonadherence. an increased risk of death [7, 8]. One study has addressed
international comparisons of nonadherence in hemodial-
ysis with a descriptive approach [9], based on question-Key words: nonadherence, noncompliance, DOPPS, outcomes, hemo-
dialysis, skipping treatments. naires mailed to health professionals caring for hemodi-
alysis patients in different countries; associations withReceived for publication October 30, 2002
patient outcomes were not examined.and in revised form January 31, 2003
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manifest lower mortality and fewer hospitalizations. It information was obtained approximately every 4 months,
was designed to provide an international perspective on including dates, diagnoses, and procedures associated
the magnitude, distribution, and predictors of nonadher- with each hospitalization.
ence (both at patient and facility level).
Measures of nonadherence
The patient measures of nonadherence used in thisMETHODS
study are skipping one or more dialysis sessions in 1
Data source month, shortening one or more dialysis sessions by more
The patient sample was drawn from the DOPPS data- than 10 minutes in 1 month, serum potassium concentra-
base, which includes information about hemodialysis pa- tion of 6.0 mEq/L, phosphate level of 7.5 mg/dL, or
tients in Japan, the United States, and five European interdialytic weight gain (IDWG)5.7% of body weight
countries (France, Germany, Italy, Spain, and the United (the last cut-off was based on a 4 kg IDWG in a 70
Kingdom, collectively referred to as Euro-DOPPS). A kg patient). IDWG was obtained using the intradialytic
nationally representative sample of dialysis facilities was weight loss, with the assumption that all the weight
enrolled in each country, followed by selection of a random gained in the interdialytic interval was lost during the
sample of hemodialysis patients at each participating dialysis session. These definitions are identical to those
center. The study design and data collection instruments used in a prior publication from a USRDS special study
were uniform across nations. Data on nonadherence [8]. A session missed because of hospitalization was not
were collected at each dialysis facility by a center-based considered nonadherence. IDWG was estimated using
research coordinator. Details of study design, facility the amount of weight removed during a hemodialysis
sampling, patient sampling, and data collection have session and was expressed as the percentage of body
been published previously [10]. weight removed. The prevalence of each adherence mea-
A data validation study was carried out in all five sure was calculated for the initial round of patients at
European countries by the contracting research organi- time of entry into the study. Skipping and shortening
zation (CRO) in Europe. The CRO extracted data from status were evaluated for the 30 days prior to enrollment
a sample of dialysis facilities, which was compared with into the DOPPS. IDWG was calculated from the most
the data extracted by the staff at those facilities. While recent hemodialysis treatment before enrollment, and
a formal data validation has not been conducted for potassium and phosphorus measurements were those ob-
the United States facilities, the values for age, diabetes tained on or before the enrollment date.
mellitus as a primary cause of ESRD, and proportion of
Practice pattern and mortality models included all pa-
female and African American patients in the United
tients enrolled and used data at the time of their entryStates-DOPPS sample are very similar to the values re-
into the study.ported for the 1997 United States population of in-center
hemodialysis patients by the United States Renal Data Statistical analysis
System (USRDS) [11], suggesting that the United States-
The prevalence of each nonadherence measure wasDOPPS data are indeed representative of the United
calculated in each participating continent for the initialStates ESRD population.
cross section of prevalent patients entering the study.The current study reflects data obtained from the
To avoid the influence of residual renal function on urineUnited States (145 facilities, 3359 patients), Euro-DOPPS
output and, hence, IDWG, patients who had been on(101 facilities, 2337 patients), and Japan (65 facilities,
dialysis for less than 90 days were removed from the1980 patients). An average of 30 adult chronic hemodial-
prevalence calculations, and adjustments were made inysis patients (age17 years) participated from each facil-
all models for patients who had been on hemodialysisity. Study patients who departed from a facility were
for less than 1 year. Linear mixed models were used toperiodically replaced with patients who started hemodi-
compare the prevalence of each nonadherence measurealysis treatment at the facility. Data collection began in
among the continents, taking into account facility cluster-the United States in June 1996, in Europe in May 1998,
ing. The nonadherence measures of IDWG, potassium,and in Japan in February 1999. For the mortality analy-
and phosphate were adjusted for the day of the week ofses, patients were followed until January 2002 in the
the blood draw. All patients were adjusted to a Wednes-United States, November 2000 in Europe, and October
day blood draw value to ensure comparability.2001 in Japan. Data were collected using a standardized
Predictors of nonadherence were identified using lo-chart abstraction procedure performed by a facility-
gistic regression. Model specification included age, race,based coordinator at each dialysis center. Data included
ethnicity, gender, diabetic ESRD, depression (presencedemographic characteristics and comorbid conditions.
or absence of a diagnosis of depression in the past 12For this analysis, data from an initial cross section of
patients (i.e., prevalent patients) were used. Follow-up months was obtained from the DOPPS Medical Ques-
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tionnaire), facility size, years on dialysis, smoking, educa- of 7676 patients used in the predictors of nonadherence
analysis; the full sample was used for the mortality andtion, living status, marital status, employment, and prior
failed transplantation. These models also took into ac- practice pattern analyses. The demographic profile of
the initial cross section of patients is given in Table 1.count facility clustering. The results were expressed as
adjusted odds ratios. The proportion of African Americans was higher in the
United States (33.5%) compared with Euro-DOPPSCox proportional hazards models were used to express
the strength of the relationship between each measure (1.6%) and Japan (0%). While the age groups were quite
similar across nations, all comorbid conditions, exceptof nonadherence and both mortality and hospitalization.
Mortality models examined time to death, while hospital- smoking and other cardiac conditions, were more preva-
lent in the United States. Employment status for thoseization models examined time to first hospitalization
after enrollment into the study. Adjustments were made 18 to 60 years old was highest for Japan (51.1%) and
lowest for the United States (13.7%); disability ratesfor the same variables used in the logistic regression
analysis and were supplemented with 15 summary co- were lowest for Japan (4.9%) and higher for the United
States (25.5%) and Euro-DOPPS (20.3%). The propor-morbid conditions (diabetes, coronary heart disease,
congestive heart failure, other cardiovascular diseases, tion of nursing home residents was highest for the United
States (8.1%), and equivalent for Euro-DOPPS (2.3%)hypertension, cerebrovascular disease, peripheral vascu-
lar disease, lung disease, cancer, HIV/AIDS, gastrointes- and Japan (2.6%). The percentage of married patients
was highest for Japan (70.7%) versus 63.5% for Euro-tinal bleed, neurologic disease, psychiatric disorder, cel-
lulitis/gangrene, and dyspnea) and facility clustering effects. DOPPS and 47.5% for the United States. Time on ESRD
was longest for Japan (6.9  6.5 years).Cox models were stratified by continent. Facility cluster-
ing effects were addressed using robust standard esti-
Distribution of nonadherence measuresmates based on the sandwich estimator [12]. A separate
model was determined for each measure of nonadher- Table 2 shows the prevalence of each parameter of
nonadherence studied. In the United States, 7.9% ofence, as was a model that included all five nonadherence
measures. For measuring the association between hyper- patients skipped one or more hemodialysis sessions/
month compared with only 0.6% in Euro-DOPPS andphosphatemia and mortality, intact parathyroid hormone
(PTH) levels were included in the model, as phosphate 0.6% in Japan. Similarly, more United States patients
shortened a hemodialysis session by 10 minutes or morelevels could, in part, reflect underlying hyperparathy-
roidism. The median follow-up time in each continent in a month (19.6%) compared with 9.8% in Euro-
DOPPS and 5.7% in Japan. For patients with excessivewas as follows: Euro-DOPPS  1.8 years, Japan  2.0
years, and the United States  2.9 years. IDWG, the distribution was highest in Japan (34.5%)
compared with 16.8% in the United States and 11.0%Logistic regression also was employed to investigate
the relationship between facility practice patterns and in Euro-DOPPS. Hyperphosphatemia 7.5g/dL was
present among 15.4% of patients in the United States,patient nonadherence. Practice patterns investigated in-
cluded facility size, percentage of highly trained staff 12.8% in Euro-DOPPS, and 12.1% in Japan. Finally,
hyperkalemia of 6.0 mEq/L was seen more commonlyhours in relation to direct patient care staff hours, per-
centage of highly trained staff (defined as having 2 or in Euro-DOPPS (20.0%) than in Japan (7.6%) or the
United States (6.3%).more years of formal nursing training), presence of a
dietitian in the unit, and physician/patient contact time
Patient level predictors of nonadherence(minutes/month). These models were adjusted for the
list of comorbid conditions previously described, as well Table 3 shows the results from logistic regression anal-
yses of possible predictors of the presence of nonadher-as for the predictors of nonadherence variables and con-
tinent of residence. Models took into account facility ence among the hemodialysis populations studied. An-
alyses adjusted for all factors in this table, as well as forclustering. All analyses were carried out using SAS ver-
sion 8.2 [13]. A P value of 0.05 was considered to those in Table 1, including Kt/V and comorbidities. Pre-
dictors of higher odds of nonadherence included youngerindicate statistical significance.
age (for skipping, shortening, excessive IDWG, and hy-
perphosphatemia), female gender (for IDWG), African
RESULTS
American race (for skipping and shortening), employed
Patient demographics status (hyperphosphatemia), living alone (hyperphos-
phatemia), smoking status (skipping and IDWG), de-There were 14,930 patients available for analysis (8396
United States, 4075 Euro-DOPPS, and 2459 Japanese pression (skipping and shortening), marital status (hyper-
phosphatemia), and time on ESRD (shortening, IDWG,hemodialysis patients). The patient numbers for the ini-
tial cross section sampled were Euro-DOPPS  2337, and hyperkalemia). In addition, there exists a high de-
gree of correlation among different measurements ofJapan  1980, and the United States  3359, for a total
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Table 1. Patient characteristics
Characteristic Euro-DOPPS Japan United States Overall
Demographics
Age years (mean, SD) 60.1 (15.2) 58.9 (12.5) 60.8 (15.8) 60.3 (15.2)
Male % 59.7 62.4 55.1 57.5
African American % 1.6 0.0 33.5 19.8
Hispanic % 0.0 0.0 9.4 5.4
Comorbidities %
Coronary heart disease 29.3 20.5 49.1 39.4
Congestive heart failure 25.1 8.8 45.9 34.6
Other cardiac conditions 34.2 24.6 32.1 31.5
Hypertension 76.4 57.0 82.8 77.0
Peripheral vascular disease 21.7 12.1 25.9 22.6
Cardiovascular disease 12.6 13.0 18.9 16.3
Diabetesa 22.6 27.9 49.1 38.8
Lung disease 10.0 1.5 13.9 10.9
Cancer (other than skin) 10.3 5.9 10.7 9.8
HIV/AIDS 0.1 0.0 1.3 0.8
Gastrointestinal bleeding 5.9 4.1 8.5 7.1
Neurologic disease 5.9 5.0 10.8 8.6
Psychiatric disorder 22.8 2.9 25.6 21.3
Recurrent cellulitis 5.5 2.5 9.8 7.5
Dyspnea 21.0 4.0 34.1 26.0
Smoking 19.6 26.5 21.1 21.6
Employment statusb %
Employed 27.7 51.1 13.7 24.1
Disabled 20.3 4.9 25.5 20.4
Education %
Less than 12 years 52.7 20.1 26.8 32.6
Some college 10.8 9.9 19.6 15.7
Living status %
Alone 14.7 9.6 15.7 14.5
Friends/family 83.0 87.5 75.8 79.5
Nursing home 2.3 2.6 8.1 5.7
Homeless/prisoner 0.0 0.3 0.4 0.3
Married % 63.5 70.7 47.5 55.4
Prior kidney transplant % 11.1 1.4 4.9 6.0
Time on ESRD years (mean, SD) 3.84 (5.4) 6.86 (6.5) 1.9 (3.3) 3.2 (4.9)
Average Kt/V single pool (mean, SD) 1.29 (0.31) 1.32 (0.28) 1.31 (0.30) 1.31 (0.30)
ESRD is end-stage renal disease.
a Primary or contributing
b Age 60 years
Table 2. Distribution of nonadherence measures by continent
Patients %
Nonadherence measure Euro-DOPPS Japan United States Overall
Skipped  1 hemodialysis session/montha 0.6 0.6 7.9 3.8
Shortened session by  10 minutesb 9.8 5.7 19.6 13.0
IDWG  5.7% of dry weight 11.0 34.5 16.8 19.6
PO4  7.5 g/dL 12.8 12.1 15.4 13.7
K  6 mEq/L 20.0 7.6 6.3 10.8
IDWG is interdialytic weight gain.
a One session skipped (N  136) (46.6%); two sessions skipped (N  67) (23.0%); and three or more sessions skipped (N  89) (30.4%)
b One session shortened (N  370) (37.0%); two sessions shortened (N  231) (23.1%); and three or more sessions shortened (N  399) (39.9%)
nonadherence (Table 4). For any given measure of non- Correlates of nonadherence with mortality
adherence, the odds of any other measure of nonadher- Table 5 shows the relative risk (RR) of mortality for
ence were greater than 1.0 and the majority of these each of the five measures of nonadherence for all DOPPS
odds ratios (OR) were statistically significant. The high- countries. Skipping one or more dialysis sessions a month
est correlation was seen between shortening and skipping (versus not skipping) was associated with a relative mor-
tality risk of 1.30 (P  0.01). The relative mortality riskshemodialysis sessions (OR  4.91; P  0.05).
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Table 3. Factors associated with nonadherencea
Odds ratios (OR) by nonadherence measure
Characteristic Skip Shorten IDWG PO4 K
Demographics
Age (per 10 years) 0.87b 0.93b 0.85b 0.75b 0.99
Male (vs. female) 1.00 0.96 0.82b 0.99 1.03
African American (vs. non-African American) 2.11b 1.31b 0.89 0.76b 0.78b
Hispanic (vs. non-Hispanic) 1.26 1.21 1.12 1.08 1.03
Employment status
Employed 1.16 0.95 0.92 1.21b 1.05
Disabled 1.00 1.00 1.00 1.00 1.00
Unemployed and not disabled (reference) 1.00 1.31b 1.31b 1.04 1.12
Education
Less than 12 years 1.31 1.13 1.02 1.07 1.09
12 years (reference) 1.00 1.00 1.00 1.00 1.00
Some college 0.98 0.99 1.01 0.93 0.87
Living status
Alone 1.09 1.07 1.01 1.22b 0.95
Friends/family (reference) 1.00 1.00 1.00 1.00 1.00
Nursing home 0.53b 1.15 1.18 0.79 1.14
Homeless/prisoner 1.36 0.82 0.80 1.32 —
Smoker (yes vs. no) 1.53b 1.14 1.43b 1.10 0.96
Depressed (yes vs. no) 1.62b 1.22b 0.96 0.99 0.98
Married (yes vs. no) 0.90 0.93 0.92 1.21b 1.03
Prior kidney transplant (yes vs. no) 0.79 0.82 0.86 0.91 1.08
Time on ESRD (per year) 1.02 1.05b 1.07b 0.99 1.03b
ESRD is end-stage renal disease; IDWG is interdialytic weight gain.
a Adjusted for continent of residence and all factors listed here and in Table 4
b P  0.05
Table 4. Associations of nonadherencea
Odds ratios (OR) by nonadherence measure
Characteristic Skip Shorten IDWG PO4 K
Skipped  1 hemodialysis session/month — 4.36b 1.40b 1.37b 1.14
Shortened session by  10 minutes 4.91b — 1.56b 1.59b 1.16
IDWG  5.7% of dry weight 1.33 1.53b — 1.36b 2.31b
PO4  7.5 mg/dL 1.36b 1.51b 1.35b — 2.14b
K  6 mEq/L 1.21 1.11 2.30b 2.12b —
IDWG is interdialytic weight gain.
a Adjusted for continent of residence and all factors listed here and in Table 3. This table does not represent a correlation matrix but instead presents the results
from five different logistic regression models.
b P  0.05
Table 5. The relative risk (RR) of mortality and first hospitalization by nonadherence measures
RR of mortality (95% CI) RR of hospitalization (95% CI)
Nonadherence measure Univariate adjusteda Multivariate adjustedb Univariate adjusteda Multivariate adjustedb
Skipped  1 hemodialysis session/month 1.33 (1.09–1.63) 1.30 (1.06–1.59) 1.16 (1.02–1.32) 1.13 (1.01–1.28)
Shortened session by  10 minutes 1.14 (0.99–1.30) 1.11 (0.97–1.27) 1.10 (1.00–1.21) 1.09 (0.99–1.19)
IDWG  5.7% of dry weight 1.14 (1.01–1.28) 1.12 (1.00–1.26) 1.00 (0.92–1.08) 1.00 (0.92–1.08)
PO4  7.5 g/dL 1.19 (1.09–1.30) 1.17 (1.07–1.28) 1.07 (1.00–1.14) 1.07 (1.00–1.14)
K  6 mEq/L 1.12 (1.00–1.26) 1.09 (0.97–1.22) 0.96 (0.88–1.05) 0.96 (0.88–1.05)
IDWG is interdialytic weight gain.
a Adjusted for factors listed in Table 1 and country (used as strata variable in the Cox model)
b Adjusted for factors listed in Table 1, other nonadherence measures, and country (used as strata variable in the Cox model)
for excessive IDWG and for phosphate levels 7.5 P 0.14) and hyperkalemia (RR 1.09; P 0.14) were
not statistically significant. The measures of nonadher-mg/dL were 1.12 (P 0.05) and 1.17 (P 0.001), respec-
tively. The RR for the association between mortality ence were independently associated with higher mor-
tality. The presence of comorbid conditions showed aand hyperphosphatemia increased to 1.27 (P  0.0001)
following adjustment for intact PTH levels. The RR asso- significant increase in mortality, as did lower dialysis
dose.ciated with shortening dialysis treatments (RR  1.11;
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Table 6. Practice patterns associated with nonadherence measuresa association was seen between IDWG and physician/
patient contact time (OR  1.01 per 10 minutes/month,Odds ratio
P  0.05).Practice pattern (individual models) Skip Short IDWG
Facility size
Per 10 patients 1.03b 1.03c 1.02b DISCUSSION
Facility  60 patients (vs.  60 patients) 1.77c 1.30 0.97
Facility  75 patients (vs.  75 patients) 1.50b 1.57c 1.03 Hemodialysis places multiple and unavoidable de-
Facility  125 patients (vs.  125 patients) 1.15 1.07 1.43c mands on a patient’s lifestyle, related to the dialysis
% Highly trained staff hours (per 10%) 0.84c 0.94 1.04
regimen, dietary and fluid restrictions, the requirement% Highly trained staff (per 10%) 0.89b 1.00 1.04
Dietitian in unit (yes/no) 1.22 1.07 0.75b for multiple medications with potential side effects, as
Physician contact time (per 10 min/month) 0.97 0.99 1.01c well as management of multiple comorbid conditions.
IDWG is interdialytic weight gain. Nonadherence with various aspects of management is
a Adjusted for variables in Table 1, country, and facility clustering
not uncommon and is understandable from the patient’sb 0.05  P  0.10
c P  0.05 perspective. Quantification of the degree of nonadher-
ence is clearly required to understand the impact of treat-
ment on a patient’s life. But solutions to this problem
are difficult, and multiple aspects of therapy have to beCorrelates of nonadherence with hospitalization
addressed [4]. However, consensus does not exist as to
Table 5 also shows the RR for hospitalization (mod- what these ought to be. The National Kidney Founda-
eled as time to first hospitalization after entering the tion/Kidney Disease Outcomes Quality Initiative Clini-
study) for each of the five measures of nonadherence cal Practice Guidelines pertaining to patient adherence
for all DOPPS countries. Skipping one or more dialysis rightly emphasize compliance with hemodialysis itself
sessions a month (versus not skipping) was associated but do not address other aspects of patient nonadherence
with a RR of 1.13 (P  0.04) for hospitalization. For [14]. While no gold standard exists, the sensitivity and
phosphate levels 7.5 mg/dL the RR was 1.07 (P  specificity of the cut-off values used in this study are not
0.05). The RR results for shortening dialysis treatments known and may have influenced the results.
(RR  1.09; P  0.09), excessive IDWG (RR  1.00; No prior international comparisons of this magnitude
P  0.91), and hyperkalemia (RR  0.96; P  0.34) and detail are available. A brief publication by Bleyer
were not statistically significant. et al [9] reports a cross-sectional analysis based on a
survey of 86 nurses and nephrologists from Japan (N 
Correlates of nonadherence with facility 21), Sweden (N  16), and the United States (N  49).
practice patterns They concluded that nonadherence (based on “missed
Dialysis facility size and certain facility practice pat- dialysis” treatments as the main outcome measure) was
terns were found to be significantly associated with non- much more common in the United States compared with
adherence measures (Table 6). Larger facility size (per Sweden and Japan and recommended further study to de-
10 more hemodialysis patients) was associated with an termine the significance of their results for patient survival.
increased likelihood of skipping (OR  1.03, P  0.06), In this study of representative samples of hemodialysis
shortening (OR  1.03, P  0.05), and IDWG (OR  patients from seven countries, measurable indices of
1.02, P  0.07). When looking for an optimum facility nonadherence that have been published previously [8]
size, it was found that the risk of skipping significantly were related to patient outcomes. Behavioral compliance
increased at a facility size of 60 patients (OR  1.77, measures of skipping dialysis and shortening dialysis
P  0.001; reference group facility size 60 patients). times were studied, as well as indirect measures of dietary
The odds of shortening sessions increased significantly and medication compliance such as IDWG, serum phos-
in facilities with more than 75 patients (OR  1.57, P  phate levels, and serum potassium levels. By adjusting
0.006; reference group facility size 75 patients), while for patients who had been on dialysis for less than 1
the odds for excessive IDWG went up significantly at a year, an attempt was made in this study to account for
facility size of 125 patients or more (OR  1.45, P  the confounding influence of residual renal function on
0.03; reference group facility size 125 patients). For a IDWG. To account for the possibility of survival bias
10% increase in highly trained staff hours, there was a that could potentially influence results in an analysis of
decrease in the likelihood of skipping (OR  0.84, P  a cross section of prevalent patients, all analyses were
0.02). Odds of skipping were 11% lower for every 10% adjusted for multiple covariates, including years on he-
increase in highly trained staff in the unit (OR  0.89, modialysis. It also was thought desirable to express
P  0.06). The presence of a dietitian in the facility was IDWG as a percentage of body weight, because absolute
associated with a lower likelihood of nonadherence in values can have different implications for individuals of
different weight. Furthermore, for the purposes of thisterms of IDWG (OR  0.75, P  0.08), while a positive
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study, intradialytic weight loss served as a proxy for [8, 19], although this remains a controversial subject [20].
IDWG since data on weights determined for two consec- The magnitude of mortality risk associated with skipping
utive sessions were not uniformly available. Phosphate dialysis seems almost as large as that predicted from the
levels above 7.5 mg/dL were more likely to reflect nonad- dose effect alone (with Kt/V in the model, the RR for
herence with diet and/or medication than levels between mortality was 1.28, P  0.05). This suggests that the
5.5 mg/dL and 6.5 mg/dL. These latter levels could exist detrimental effect of skipping on mortality risk is inde-
despite a patient’s attempt at adherence with diet and pendent of the delivered dialysis dose and that other
drugs [15, 16], the result of the relatively inefficient phos- detrimental factors or behaviors associated with skipping
phate clearance achieved by conventional three times a dialysis may contribute to the mortality risk. Hyperphos-
week hemodialysis [17]. phatemia was significantly associated with a higher RR
Analysis revealed significant correlations between dif- of mortality, confirming previous reports [21]. It is recog-
ferent measures of nonadherence. Results in this regard nized that hyperphosphatemia may not simply reflect
are in agreement with the study by Leggat et al [8] but nonadherence with regard to diet. It may also be second-
at variance with Kimmel et al [18]. In the latter study, ary to hyperparathyroidism, as well as underdialysis.
at three urban hemodialysis centers in the United States When the mortality analyses were adjusted for intact
with predominantly African American populations, no PTH levels, the association between hyperphosphatemia
correlation was observed between skipping and shorten- and mortality seemed to strengthen. Hyperkalemia above
ing behavior. The authors reasoned that this possibly 6.0 mEq/L failed to achieve statistical significance with
reflected different underlying behavioral causes for skip- respect to RR of mortality. The latter finding, however,
ping versus shortening. should not lull practicing nephrologists into ignoring
Multiple demographic characteristics were observed marked hyperkalemia as a risk factor for mortality in an
in this study to predict patient nonadherence (Table 3). individual patient and may indicate that the criterion of
Younger age, African American race, female gender, hyperkalemia is not always indicative of nonadherence
disabled status, living alone, smoking, depression, and and may be dependent upon variations in dietary pattern.
time on ESRD were associated with higher odds of non- Few studies have looked at the effect of nonadherence
adherence with one or more of the measurements of on mortality. Held et al [7] reported a 14% higher risk
nonadherence. Some college education and prior kidney of death from a single skipped session in one month.
transplant were associated with neutral odds of nonad- Ifudu, Henry, and Friedman [22], however, reported no
herence in all the domains studied. Living in a nursing increased risk. Leggat et al [8], based on a USRDS spe-
home was associated with 47% lower odds of skipping cial study, reported definite mortality associations with
treatment, perhaps owing to staff supervision and pre-
nonadherence with respect to skipping or shortening ses-
dictable transportation arrangements to and from the
sions. Based on their analysis, one or more skipped he-dialysis unit. A number of patient comorbidities tested
modialysis session per month was associated with a 25%were not significantly associated with nonadherence.
higher risk of death (P 0.01). Shortening three or moreSkipping and shortening hemodialysis treatments is
sessions, excessive IDWG, and hyperphosphatemia alsomuch more common in the United States than in Euro-
correlate with heightened mortality risk, as in this study.DOPPS or Japan. Excessive IDWG was more prevalent
Greater IDWG is associated with better nutritional indi-in Japan, followed by the United States and Euro-
ces and lower mortality in a Japanese hemodialysis regis-DOPPS. High phosphate was almost equally prevalent
try report [23], as well as in a single-center study byin each of the three geographic regions, and potassium
Testa and Beaud [24]. However, these results support thelevels of 6.0 mEq/L were more prevalent in Euro-
contention that, after adjustments for age, race, gender,DOPPS compared with Japan and the United States.
ethnicity, time on ESRD, 15 summary comorbid condi-Furthermore, while skipping one or more dialysis ses-
tions, depression, smoking status, education, employ-sions in a month was associated with a 30% increased
ment, and living status, high IDWG is associated with amortality risk compared with not skipping, shortening
higher mortality risk. It is conceivable that the “J-shaped”dialysis time was associated with an 11% higher RR of
relationship suggested in the literature [23, 24] is notmortality than not shortening. Whereas the latter failed
seen because of adjustments made in this study for theto reach statistical significance, the effect was in the ex-
variables that would possibly be correlated with lowpected direction and likely to be of clinical relevance,
IDWG (e.g., age, nursing home residence, depression,as shortening dialysis time represents a behavioral ten-
and comorbidity). The high mortality risk is perhapsdency to other measures of nonadherence in such pa-
secondary to excessive cardiovascular burden related totients. Skipping dialysis decreases the total delivered
expanded extracellular volume. It has been reasoneddose and may affect mortality by that mechanism. Dose
quite convincingly that excessive salt intake increasesof dialysis previously has been shown to have a relation-
ship with RR of mortality in large observational studies thirst, and patients should be counseled to restrict salt
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intake in the first instance so as to significantly reduce CONCLUSION
their water intake [25]. This is the first comprehensive international report
The data pertaining to hospitalization as an outcome on nonadherence in hemodialysis. Measures described
of nonadherence (Table 5) indicate that skipping dialysis include prevalence, patient and facility-level predictors,
is a significant risk factor for hospitalization (with a 16% and hospitalization and mortality associations. Nonad-
herence, as measured by skipping and shortening hemo-higher risk of hospitalization in those who skipped one
dialysis treatments, was more prevalent in the Unitedor more sessions of hemodialysis in a month versus those
States than in Euro-DOPPS and Japan. Japan demon-who did not skip). The risk of hospitalization was 7%
strated the highest prevalence of IDWG per dry weight.higher in those with a phosphate level7.5 mg/dL. These
After adjustments for multiple covariates, increasedresults are consistent with the mortality data. Previous
mortality risk was associated with skipping and shorten-studies have not looked at hospitalization as an outcome
ing dialysis sessions, high IDWG, and hyperphosphate-while evaluating nonadherence, despite its importance
mia. Risk of hospitalization was significantly higher forwith regard to patient morbidity and its effect on cost
those patients who skipped dialysis sessions and ran high
of care.
phosphate levels, with implications for patient morbidity
Facility size was correlated by group to see if this was and thus cost to health care systems. Larger facilities
a consistent linear pattern. As shown in Table 6, smaller were more likely to encounter a higher level of nonad-
facilities (lowest quartile) were associated with the ob- herence, especially with respect to skipping and shorten-
servation on skipping, while the larger facilities (highest ing dialysis. Highly trained staff may help to decrease
quartile) were associated with IDWG. Thus, facilities nonadherence. The presence of a dietitian in the facility
with more than 60 patients had a significantly higher OR was found to lower the odds of excessive IDWG. Appro-
of skipping dialysis (1.77, P  0.001) and those with priate measures to minimize the nonadherence among
more than 75 patients had a significantly higher OR of patients (both at the patient and facility levels) are likely
to reduce mortality and hospitalization risks in hemodial-shortening dialysis (1.57, P  0.006). It was only when
ysis patients. Further research into effective ways to min-facility size exceeded 125 patients that a significantly
imize nonadherence rates must continue in order to im-higher OR was detected for IDWG. This analysis, the
prove outcomes among hemodialysis patients.authors believe, is the first to report a relationship be-
tween facility size and measures of patient nonadher-
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